Stock options take Takeda execs' pay past CEO
This article was originally published in Scrip
Executive Summary
Yasuchika Hasegawa, the president and CEO of Asia's largest pharmaceutical company Takeda, was not surprisingly one of the highest paid pharma executives in Japan last year. But his earnings were overshadowed by three other senior executives within the company who all had total compensation packages worth more than double the chief executive's, with stock options accounting for most of the gap.